Dr. Reddy's Laboratories Limited (RDY)

NYQ – Real Time Price. Currency in USD

12.85

+0.39 (3.13%)

Market open: May 13, 2026, 10:02 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2024

2023

2022

2021

Total Revenue

3.85B

3.37B

3.06B

2.88B

Cost of goods sold

-1.72B

-1.49B

-1.41B

-1.43B

Gross Profit

2.13B

1.88B

1.65B

1.44B

Operating expenses (excl. COGS)

-1.31B

-1.11B

-1B

-982M

Operating Income

822M

772M

650M

463M

Non-operating income, total

84M

95M

97M

-39M

Pretax income

906M

866M

747M

424M

Equity in earnings

Taxes

-231M

-196M

-190M

-117M

Non-controlling/minority interest

-8M

After tax other income/expense

Net income before discontinued operations

669M

673M

561M

316M

Dr. Reddy's Laboratories Limited (RDY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Dr. Reddy's Laboratories Limited (RDY)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Dr. Reddy's Laboratories Limited (RDY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Dr. Reddy's Laboratories Limited (RDY)

Income Statement (Annual)

Income Statement (Annual)